Skip to main content

Azacitidine Injection

Last Updated: December 14, 2022
Status: Current

Products Affected - Description
    • Azacitidine lyophilized powder for injection, Cipla USA, 100 mg, vial, 1 count, NDC 69097-0805-40
    • Azacitidine lyophilized powder for injection, Mylan Institutional (Viatris), 100 mg, vial, 1 count, NDC 67457-0254-30 - discontinued
    • Azacitidine lyophilized powder for injection, Wockhardt USA, 100 mg, vial, 1 count, NDC 64679-0096-01 - discontinued
Reason for the Shortage
    • Accord had azacitidine on back order due to a shortage of the raw ingredient.
    • Armas has azacitidine injection available.
    • Cipla does not expect more supply in the near future.
    • Celgene (now part of Bristol-Myers Squibb) had Vidaza on shortage due to increased demand.
    • Dr. Reddy's has azacitidine injection available.
    • Fresenius Kabi has azacitidine injection available.
    • Hikma has azacitidine injection available.
    • Meitheal has azacitidine injection available.
    • Sandoz has azacitidine injection available.
    • Viatris discontinued azacitidine in September 2022.
    • Wockhardt discontinued azacitidine in mid-2022.
Available Products
    • Vidaza lyophilized powder for injection, Bristol-Myers Squibb, 100 mg, vial, 1 count, NDC 59572-0102-01
    • Azacitidine lyophilized powder for injection, Accord, 100 mg, vial, 1 count, NDC 16729-0306-10
    • Azacitidine lyophilized powder for injection, Armas Pharmaceuticals, 100 mg, vial, 1 count, NDC 72485-0201-01
    • Azacitidine lyophilized powder for injection, Dr. Reddy's, 100 mg, vial, 1 count, NDC 43598-0305-62
    • Azacitidine lyophilized powder for injection, Dr. Reddy's, 100 mg, vial, 1 count, NDC 43598-0143-62
    • Azacitidine lyophilized powder for injection, Fresenius Kabi, 100 mg, vial, 1 count, NDC 63323-0771-39
    • Azacitidine lyophilized powder for injection, Hikma, 100 mg, vial, 1 count, NDC 00143-9606-01
    • Azacitidine lyophilized powder for injection, Meitheal Pharmaceuticals, 100 mg, vial, 1 count, NDC 71288-0115-30
    • Azacitidine lyophilized powder for injection, Sandoz, 100 mg, vial, 1 count, NDC 00781-3253-94

Estimated Resupply Dates

    • Most marketed presentations are available.

Updated

Updated December 14, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 2, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer